Many educational resources (eg, television, Internet) available to patients with type 2 diabetes mellitus (T2DM) have been known to misrepresent data and propagate misperceptions about current and emerging treatment options. This type of misinformation can contribute to poor T2DM management and often complicates the provider-patient relationship.
Despite several recent therapeutic advances, patients with T2DM continue to fall short of achieving glycemic targets. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as a valuable class of antihyperglycemic agents for patients with T2DM, but more education regarding their role in T2DM treatment is needed. This activity is designed to help participants recognize that GLP-1RAs can provide effective glycemic control with several nonglycemic effects that frequently align with individual patient characteristics and goals. Additionally, tools to better manage provider-patient discussions and aid patients in identifying reputable education sources will be provided.